How Immunotherapy Is Rewriting the Rules of Liver Cancer Treatment
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A preclinical study shows that CAR-T cells engineered to secrete an Fc-fused IL-2(C125S) variant persist longer, retain mitochondrial fitness, and ...
A new dual-targeting radioligand that binds both fibroblast activation protein and integrin αvβ3 showed sixfold higher tumor uptake than a ...
A new review details how microbial imbalances in the gut, airways, mouth, and tumors drive lung cancer progression and undermine ...
A phase II trial found that neoadjuvant camrelizumab plus apatinib, a chemotherapy-free combination of immunotherapy and anti-angiogenic therapy, produced manageable ...
A new review details how enzymes that degrade the extracellular matrix and glycocalyx could open solid tumors to immune attack, ...
A new single-cell study identifies the transcription factor RBPJ and CD103-positive tissue-resident memory T cells as central drivers of successful ...
A multi-omics study finds that LDL cholesterol metabolism reshapes macrophages and tumor cells in head and neck squamous cell carcinoma, ...
A new integrative study identifies three lipid metabolism-related long non-coding RNAs that predict survival, immune landscape, and drug sensitivity in ...
A first-of-its-kind multi-omics study shows that dogs and humans share key genetic drivers and conserved tumor microenvironment features in hepatocellular ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine